Embryo and Egg Storage Insurance Denied? How to Appeal Cryopreservation Coverage

Cryopreservation — the freezing and long-term storage of embryos, eggs (oocytes), or sperm — is a cornerstone of modern reproductive medicine. For cancer patients facing treatments that will destroy their fertility, it can be the only path to biological parenthood. For others undergoing IVF, it preserves viable embryos for future transfer attempts. When insurance denies coverage for cryopreservation or ongoing storage fees, patients are left with bills that often exceed thousands of dollars per year. These denials are not always final.

Types of Cryopreservation Coverage Disputes

Oncofertility Cryopreservation

Oncofertility refers to fertility preservation for patients about to undergo cancer treatment — chemotherapy, radiation, or surgery — that is likely to cause permanent gonadal damage. Egg freezing, embryo freezing, and sperm banking before cancer treatment are time-sensitive medical procedures with direct clinical justification.

An increasing number of states, insurers, and employer plans have begun covering oncofertility services. Critically, this coverage is typically justified under the medical benefit rather than the fertility benefit, because the indication is not primary infertility — it is preservation of fertility at risk due to a covered medical condition (cancer). Appeals for oncofertility cryopreservation should frame the service as medically necessary treatment for the sequelae of cancer, not as elective fertility treatment.

Key ICD-10 codes for oncofertility: The correct coding often pairs the cancer diagnosis (e.g., C50.x for breast cancer) with a code for the fertility preservation service. Your reproductive endocrinologist's billing department should be using the most current oncofertility coding conventions.

Annual Storage Fees

Even when the initial cryopreservation procedure is covered, most insurers do not cover annual storage fees charged by the fertility clinic or cryobank — typically $500–$1,000 per year. These fees are almost universally categorized as a non-covered "maintenance" or "custodial" service.

Appeals for storage fee coverage succeed less frequently than procedure coverage appeals, but there are grounds in specific cases:

• Oncofertility patients: storage is an extension of the medically necessary preservation procedure
• Patients awaiting an eligible transfer cycle under a covered IVF benefit: storage during active treatment is arguably part of covered IVF
• State mandates that explicitly include storage: some state infertility mandates reference ongoing storage as a covered component — check your state statute

IVF Embryo Storage During Active Treatment

If a patient has undergone covered IVF and has frozen embryos in storage while awaiting a frozen embryo transfer (FET) that is also a covered service, the storage period bridging the two covered events has a logical coverage argument. Document the medical necessity of the storage period — for example, the patient needed time for endometrial preparation, or an FET was medically contraindicated for a specific period.

Appealing a Cryopreservation Denial

Step 1: Identify the correct benefit category. Is this claim under the fertility benefit or the medical/surgical benefit? Oncofertility should be the latter. Resubmitting under the correct benefit category may resolve the denial without a full appeal.

Step 2: Obtain the oncologist's documentation. A letter from the treating oncologist stating that the planned cancer treatment carries a significant risk of permanent infertility and that fertility preservation is medically indicated is essential. Reference the relevant cancer diagnosis, planned chemotherapy agents or radiation fields, and the evidence that gonadotoxicity is expected.

Step 3: Cite ASCO and ASRM guidelines. The American Society of Clinical Oncology (ASCO) and the American Society for Reproductive Medicine (ASRM) both publish guidelines recommending timely discussion and facilitation of fertility preservation for cancer patients. ASCO's guideline explicitly states that oncologists should refer patients to reproductive specialists before initiating gonadotoxic treatment.

Step 4: Invoke state law if applicable. Several states have enacted oncofertility coverage laws, including Connecticut, Illinois, New York, New Jersey, Rhode Island, and others. If you are in a mandate state with a fully-insured plan, cite the specific statute in your appeal.

Step 5: Address the "elective" characterization. The core of most denials is the argument that fertility preservation is elective. Counter this directly: the procedure is not elective for a patient facing medically necessary cancer treatment that will cause permanent reproductive harm. The American Medical Association and ASRM have published position statements supporting this framing.

Employer Plans and Fertility Benefits

Many large employers now voluntarily offer fertility benefits, including coverage for IVF, egg freezing, and embryo storage. Check your employee benefits portal and Summary Plan Description. If storage fees are listed as a covered benefit in your plan documents, a denial of storage fees is a direct coverage dispute — not a medical necessity issue — and can be appealed as a wrongful claim denial under ERISA.

Fight Back With ClaimBack

ClaimBack helps patients facing cryopreservation denials build medically and legally grounded appeals. Our platform identifies the strongest arguments for your specific denial — oncofertility, storage fees, or state mandate violations — and generates a complete appeal letter.

Start your cryopreservation appeal now

Related Reading

• What Is Medical Necessity?
• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: Which Should You File?